Mirador Therapeutics, Inc. — Form D
Mirador Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-03. The offering totals $80.0M, of which $80.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-04-03
- Form: D
- Accession: 0002017193-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $80.0M
- Investors: 3
- Date of first sale: 2023-12-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509562
Issuer
- Name: Mirador Therapeutics, Inc.
- CIK: 0002017193
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 3115 Merryfield Row, Suite 210, San Diego, CA, 92121
- Phone: (858) 523-5400
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Paul K Berns | Director | San Diego, CA |
| Timothy K Andrews | Executive Officer | San Diego, CA |
| David K Bonita, M.D. | Director | San Diego, CA |
| Mark C McKenna | Director | San Diego, CA |
| Mark C McKenna | Executive Officer | San Diego, CA |
| Scott K Glenn | Director | San Diego, CA |
| Kristina K Burow | Director | San Diego, CA |
| Vika K Brough | Executive Officer | San Diego, CA |
| Joseph K Papa | Director | San Diego, CA |
Other filings by this issuer (1)
More